ORIC
Price
$12.65
Change
+$0.61 (+5.07%)
Updated
Sep 14 closing price
Capitalization
1.31B
55 days until earnings call
Intraday BUY SELL Signals
PWS
Price
$32.42
Change
-$0.27 (-0.83%)
Updated
Sep 14, 04:44 PM (EDT)
Net Assets
24.52M
Intraday BUY SELL Signals
Interact to see
Advertisement

ORIC vs PWS

ORIC vs PWS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ORIC vs. PWS commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORIC is a StrongBuy and PWS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ORIC: Fundamental Ratings
ORIC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORICPWS
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 12 days ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
70%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (ORIC: $12.65)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORIC’s FA Score shows that 1 FA rating(s) are green while .

  • ORIC’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORIC’s TA Score shows that 4 TA indicator(s) are bullish.

  • ORIC’s TA Score: 4 bullish, 5 bearish.

Price Growth

ORIC (@Biotechnology) experienced а -1.63% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

ORIC is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ORIC
Daily Signal:
Gain/Loss:
PWS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHRX36.330.03
+0.08%
Artisan Global Opportunities Instl
TGVNX30.73N/A
N/A
TCW Relative Value Mid Cap N
JCVWX23.13N/A
N/A
JHancock Classic Value R6
ATHDX26.19N/A
N/A
American Century Heritage R6
CLBAX40.11-0.24
-0.59%
American Funds American Balanced 529-A

PWS and

Correlation & Price change

A.I.dvisor tells us that PWS and RNA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PWS and RNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PWS
1D Price
Change %
PWS100%
-0.80%
RNA - PWS
22%
Poorly correlated
-1.45%
KNSA - PWS
20%
Poorly correlated
+0.41%
ORIC - PWS
19%
Poorly correlated
+5.07%
CGEM - PWS
19%
Poorly correlated
-0.92%
ZM - PWS
18%
Poorly correlated
-0.22%
More